Ribosomal Protein L22 (RPL22) (C-Term) Peptide
RPL22
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN983184
Aperçu rapide pour Ribosomal Protein L22 (RPL22) (C-Term) Peptide (ABIN983184)
Antigène
RPL22
(Ribosomal Protein L22 (RPL22))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Séquence
- TSEVPFSKRY LKYLTKKYLK KNNLRDWLRV VANSKESYEL RYFQINQDEE
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-RPL22 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- RPL22 (Ribosomal Protein L22 (RPL22))
-
Sujet
-
Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a cytoplasmic ribosomal protein that is a component of the 60S subunit. The protein belongs to the L22E family of ribosomal proteins. Its initiating methionine residue is post-translationally removed. The protein can bind specifically to Epstein-Barr virus-encoded RNAs (EBERs) 1 and 2. The mouse protein has been shown to be capable of binding to heparin. Transcript variants utilizing alternative polyA signals exist. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. It was previously thought that this gene mapped to 3q26 and that it was fused to the acute myeloid leukemia 1 (AML1) gene located at 21q22 in some therapy-related myelodysplastic syndrome patients with 3,21 translocations, however, these fusions actually involve a ribosomal protein L22 pseudogene located at 3q26, and this gene actually maps to 1p36.3-p36.2.
Alias Symbols: EAP, HBP15, HBP15/L22, L22
Protein Interaction Partner: CSE1L,NSFL1C,CD4,CDC42,CSE1L,NSFL1C,POU5F1,UBC
Protein Size: 128 -
Poids moléculaire
- 14 kDa
-
ID gène
- 6146
-
NCBI Accession
- NM_000983, NP_000974
-
UniProt
- P35268
Antigène
-
Vous êtes ici:
